Daniel M. Klotz
Dresden, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Induction of circulating ABCB1 transcripts under platinum-based chemotherapy indicates poor prognosis and a bone micrometastatic phenotype in ovarian cancer patients.
Journal: Molecular cancer
Published: June 28, 2024
The prognostic influence of hospital type, method of first histological confirmation and time to chemotherapy in patients with advanced primary ovarian cancer.
Journal: Archives of gynecology and obstetrics
Published: May 28, 2024
Urinary-based detection of MSL, HE4 and CA125 as an additional dimension for predictive and prognostic modelling in ovarian cancer.
Journal: Frontiers in oncology
Published: February 27, 2024
High serum levels of leucine-rich α-2 glycoprotein 1 (LRG-1) are associated with poor survival in patients with early breast cancer.
Journal: Archives of gynecology and obstetrics
Published: September 29, 2023
A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, HE4, mesothelin).
Journal: Clinical chemistry and laboratory medicine
Published: March 28, 2023
Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axis.
Journal: Frontiers in oncology
Published: June 21, 2022
Caravan - A global community dataset for large-sample hydrology.
Journal: Scientific data
Published: May 30, 2022
Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients.
Journal: Clinical chemistry and laboratory medicine
Published: April 27, 2021
The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker.
Journal: Molecular oncology
Published: January 20, 2021
Last Updated: 09/26/2026